Trademark Overview
On Wednesday, March 11, 2026, a trademark application was filed for WELLCOVORIN with the United States Patent and Trademark Office. The USPTO has given the WELLCOVORIN trademark a serial number of 99696467. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, March 11, 2026. This trademark is owned by Glaxo Group Limited. The WELLCOVORIN trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Anti-infectives; Vaccines